期刊名称：CHEMISTRY AND PHYSICS OF LIPIDS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Chemistry and Physics of Lipids publishes research papers and review articles in the field of molecular biology which emphasise chemical and physical aspects of lipids. Accordingly, the journal covers: advances in synthetic and analytical lipid methodology; chemical and physical characterisation of isolated structures; thermodynamics, phase behaviour, topology and dynamics of lipid assemblies; physicochemical studies into lipid-lipid and lipid-protein interactions in lipoproteins and in natural and model membranes; movement of lipids within, across and between membranes; intracellular lipid transfer; structure-function relationships and the nature of lipid-derived second messengers; chemical, physical and functional alterations of lipids induced by free radicals; and the role of lipids in the regulation of membrane-dependent biological processes. Reviews, full articles and short communications will be considered for publication in each issue. Special Issues will consist of invited contributions organized and edited to cover specific themes. |
Instructions to Authors
Submission of Manuscripts
The original and two copies, typed double-spaced with 4-cm margins, should be sent (i) from Europe to: Professor Paavo Kinnunen, University of Helsinki, Institute of Biomedicine, Haartmaninkatu 8, FIN-00290 Helsinki, Finland, and (ii) from other parts of the world to: Professor Richard M. Epand, Health Sciences Centre, Department of Biochemistry, McMaster University, 1200 Main Street West, Hamilton ONT, Canada L8N 3Z5.
A submission letter should always accompany the submitted paper providing the following information:
a) The full name and address of the corresponding author (including telephone and fax numbers, and e-mail addresses).
b) Any known changes of address within a period of six months after submission of the paper.
c)The full title of the submitted paper.
d) The names and addresses of at least three suitable potential reviewers. If there are compelling reasons for excluding some individuals as potential reviewers, these can be mentioned. However, choice of reviewers is at the editors' discretion.
e) Manuscripts cited as "in press" should be made available to referees in the form of preprints.
On-line submission as alternative for paper submission
Authors can also upload their article as a LaTeX, Microsoft?(MS) Word? WordPerfect?or PostScript or document via the "Author Gateway" page of this journal http://authors.elsevier.com, where you will also find a detailed description on its use. The system generaties an Adobe Acrobat PDF version of the article which is used for the reviewing process. It is crucial that all graphical and tabular elements be placed within the text, so that the file is suitable for reviewing. Authors, Reviewers and Editors send and receive all correspondence by e-mail and no paper correspondence is necessary.
Electronic Manuscripts
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs.
For the initial submission of manuscripts for consideration, hardcopies are sufficient. After final acceptance, your disk plus two final and exactly matching printed versions should be submitted together. Double density (DD) or high density (HD) diskettes (3 1/2 or 5 1/4 inch) are acceptable. It is important that the file saved is in the native format of the wordprocessor program used. Please do not save your text as ASCII or similar as this will cause all special formatting codes to be lost. Label the disk with the name of the computer and wordprocessing package used, your name, and the name of the file on the disk. Further information may be obtained from the Publisher.
Organization of Manuscripts
a) Title page. The title should be concise, descriptive and informative. The names of the authors should be followed by their addresses and indicated by corresponding letters. Changes in address should be indicated by footnotes. The author(s) to whom correspondence and proofs should be sent should be indicated, giving a full address (including fax number and e-mail address). Authors are requested to select a maximum of six key words and to present them on the title page of the typescript. These key words will be used for indexing and abstracting. Indicate also if the paper is a "Review" or "Short Communication".
b) Abstract. An abstract not exceeding 150 words should summarize the objectives, procedures, results and conclusions of the research. It should be typed on a separate page and will appear at the beginning of the article.
c) Presentation of material. The text should be concise and organized in the conventional manner. An Introduction should state the purpose of the work in the context of current knowledge. Experimental Procedures should be brief but sufficiently detailed to allow for potential repetition of the work by others. Results may include tables and figures, and a Discussion should primarily deal with the interpretation of the results. When appropriate, especially in Short Communications, Results and Discussion sections may be combined.
d) Acknowledgments. Financial support, technical assistance, and other help or advice should be acknowledged in a separate paragraph at the end of the text.
References
1. Quote references in the text by first author's name and year. For two authors quote both names; for three or more authors, quote first author's name, et al.
2. At the end of the article, list references alphabetically by first author; include all authors' names, followed by initials and include full titles of publications.
Examples of references: a) to Journal articles: Hupfer, B., Ringsdorf, H., 1983. Spreading and polymerization behavior of diacetylene phospholipids at the gas-water interface. Chem. Phys. Lipids 33, 263-282. b) to books: Dahlén, G., 1990. Clinical significance of Lp[a] lipoprotein. In: Berg, K., Rettersøl, N., Refsum, F. (Eds.), From Phenotype to Gene in Common Disorders. Munksgaard, Copenhagen, pp. 163-178. The names of the journals should be abbreviated according to the list of serial title word abbreviations (ISDS. Paris, 1985. ISBN 2-904938-02-8). Unpublished results should not be listed in the References section. In the text they are mentioned as follows "(Tervoort, M.V., Glimcher, J., unpublished data)". When unpublished results are cited, the data should be provided for the Editors' information when essential for proper evaluation, or if requested. A personal communication should be mentioned in the text as follows: "(Tervoort, M.V. personal communication)". Authors should not make unauthorized use of personal communications. Personal communications are not to be included in the References section.
Tables and Figures
a) Tables should be numbered separately in Arabic numerals (Table 1, 2, 3?) and must have a title.
b) Figures should be numbered in Arabic numerals (Fig. 1, 2, 3?). Illustrations will not be redrawn by the Publisher and therefore they should be submitted as either original ink drawings, computer generated prints (laser printer), or sharp, high contrast, unmounted photographs on glossy paper with the lettering proportional to the size of the illustrations taking reduction in size into account. Each illustration should be clearly marked on the reverse side with the name of the author(s), the number of the illustration and its orientation (top); use a soft pencil or preferably a felt-tipped pen. Illustrations should be designed for use in either a single column (7.5 cm) or a double column (16 cm). Actual magnification of all photomicrographs should be indicated. Reproduction in colour will have to be approved by the Editors. The extra costs of colour reproduction will be charged to the author(s).
c) The appropriate position of each table and figure should be indicated in the margin of the manuscript.
d) Legends to figures should be typed, double spaced, beginning on a separate page.
Nomenclature and Abbreviations
Standard nomenclature should be used throughout; unfamiliar or new terms, arbitrary abbreviations, and trade names should be defined when first used. Unnecessary symbols and abbreviations should be avoided.
Proofreading
Since acceptance is based upon the submitted version of the paper, it is essential that no new material be inserted in the text at the time of proofreading; furthermore, no alteration to style or meaning will be permitted at this stage. Any new material that the authors wish to introduce for reasons of scientific accuracy will be checked by the Editors, and a charge may be made for corrections. Authors are encouraged to return their proofs by fax.
Reprints
Twenty five reprints of each article will be supplied free of charge to the author(s). Additional reprints can be ordered at the prices shown on the reprint order accompanying proofs. Later orders cannot be filled since reprints are made at the time the journal is printed.
There is no page charge.
Authors can keep a track on the progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's status, by using the "Track a Paper" feature of Elsevier's Author Gateway
This journal is in the ADONIS SERVICE, whereby copies of individual articles can be printed out from CD-ROM on request. An explanatory leaflet can be obtained by writing to: ADONIS B.V., P.O. Box 993, 1000 AZ Amsterdam, The Netherlands.
Editorial Board
- Managing Editor (European submissions):
- P. Kinnunen, University of Helsinki, Institute of Biomedicine, Haartmaninkatu 8, FIN-00290 Helsinki, Finland Tel: +358 9 191 25400, Fax: +358 9 191 25444, Email: paavo.kinnunen@helsinki.fi
- Managing Editor (Rest of the World submissions):
- R.M. Epand, Health Sciences Centre, Department of Biochemistry, McMaster University, 1200 Main Street West, Hamilton ONT, Canada L8N 3Z5 Tel: +1 905 525 9140, Fax: +1 905 521 1397, Email: epand@mcmaster.ca
- Founding Editors:
- L.D. Bergelson, Moscow, Russia
D. Chapman, London, UK
J.B. Finean, Birmingham, UK
G.H. Haas de, Utrecht, The Netherlands
H.K. Mangold, Münster, Germany
D. Shapiro, Rehovot, Israel
- Editorial Advisory Board:
- Y. Barenholz, Jerusalem, Israel
A. Ben-Shaul, Jerusalem, Israel
R. Biltonen, Charlottesville, VA, USA
R. Bittman, Flushing, NY, USA
A. Blume, Halle/Saale, Germany
J.M. Boggs, Toronto, ON, Canada
R.E. Brown, Austin, MN, USA
G. Cevc, München, Germany
W.W. Christie, Dundee, UK
K. Gawrisch, Bethesda, MD, USA
F. Goni, Bilbao, Spain
T. Greibrokk, Oslo, Norway
A. Gulik, Gif-sur-Yvette, France
I. Hatta, Fukui, Japan
H. Hauser, Zürich, Switzerland
H.J. Hinz, Regensburg, Germany
D. Hoekstra, Groningen, The Netherlands
K. Jacobson, Chapel Hill, NC, USA
J.A. Killian, Utrecht, The Netherlands.
P. Laggner, Graz, Austria
D. Lichtenberg, Tel-Aviv, Israel
G. Lindblom, Umea, Sweden
D. Marsh, Göttingen, Germany
R.N. McElhaney, Edmonton, AB, Canada
T.J. McIntosh, Durham, NC, USA
J.D. Morrisett, Houston, TX, USA
O.G. Mouritsen, Lyngby, Denmark
J. Nagle, Pittsburgh, PA, USA
V. Natarajan, Indianapolis, IN, USA
Y. Nozawa, Gifu, Japan
E. Oldfield, Urbana, IL, USA
M.C. Phillips, Philadelphia, PA, USA
F. Schroeder, College Station, TX, USA
J. Seelig, Basel, Switzerland
G. Shipley, Boston, MA, USA
A. Wieslander, Stockholm, Sweden
P. Yeagle, Storrs, CT, USA
|
